APA (7th ed.) Citation

MacDougall, D., Vanderlugt, J., Rosenberg, N., DiCarlo, L., Milad, M., Margulies, J., & Newton, R. (2013). ETC-1002, A MODULATOR OF ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE AND ADENOSINE TRIPHOSPHATE-CITRATE LYASE, WAS SAFE AND REDUCED LOW-DENSITY LIPOPROTEIN-CHOLESTEROL IN HEALTHY VOLUNTEERS. Journal of the American College of Cardiology, 61(10), E1463. https://doi.org/10.1016/S0735-1097(13)61463-1

Chicago Style (17th ed.) Citation

MacDougall, Diane, James Vanderlugt, Noah Rosenberg, Lorenzo DiCarlo, Mark Milad, Janice Margulies, and Roger Newton. "ETC-1002, A MODULATOR OF ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE AND ADENOSINE TRIPHOSPHATE-CITRATE LYASE, WAS SAFE AND REDUCED LOW-DENSITY LIPOPROTEIN-CHOLESTEROL IN HEALTHY VOLUNTEERS." Journal of the American College of Cardiology 61, no. 10 (2013): E1463. https://doi.org/10.1016/S0735-1097(13)61463-1.

MLA (9th ed.) Citation

MacDougall, Diane, et al. "ETC-1002, A MODULATOR OF ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE AND ADENOSINE TRIPHOSPHATE-CITRATE LYASE, WAS SAFE AND REDUCED LOW-DENSITY LIPOPROTEIN-CHOLESTEROL IN HEALTHY VOLUNTEERS." Journal of the American College of Cardiology, vol. 61, no. 10, 2013, p. E1463, https://doi.org/10.1016/S0735-1097(13)61463-1.